Heritage Wealth Management, LLC Gilead Sciences, Inc. Transaction History

Heritage Wealth Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	BUY	$62.32 - $89.47 $8,101 - $11,631	130 Added 54.62%	368 $31,000
Q3 2022 Nov 14, 2022	BUY	$59.54 - $68.01 $6,430 - $7,345	108 Added 83.08%	238 $15,000
Q2 2022 Aug 15, 2022	BUY	$57.72 - $65.01 $519 - $585	9 Added 7.44%	130 $8,000
Q1 2022 Aug 15, 2022	BUY	$57.92 - $72.58 $1,448 - $1,814	25 Added 26.04%	121 $7,000
Q3 2021 Nov 10, 2021	SELL	$67.69 - $73.03 $6,769 - $7,303	-100 Reduced 51.02%	96 $7,000
Q1 2021 Jul 16, 2021	BUY	$60.0 - $68.46 $11,760 - $13,418	196 New	196 $13,000

1,893

1.02B

12M

9.04M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $110B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Heritage Wealth Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Heritage Wealth Management, LLC with notifications on news.